A PCR-RFLP Method for the Detection of Activated H-ras Oncogene with a Point Mutation at Codon 12 and 61

Yonsei Medical Journal

Volumn 37, Issue 6, 1996, Pages 371-379

  Hong, Sung Joon ^a   Lee, Tack ^a   Park, Young Sug ^b   Lee, Kyung Ok ^b   Chung, Byung Ha ^a   Lee, Soo Hyung ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul Medical Science Institute   (South Korea)

^c Department of Urology   (South Korea)

Author keywords

Bladder tumor; H ras gene; PCR RFLP; Point mutation

Indexed keywords

ARTICLE; BLADDER TUMOR; CODON; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSITIONAL CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, TRANSITIONAL CELL; CODON; GENE EXPRESSION REGULATION; GENES, RAS; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URINARY BLADDER NEOPLASMS;

EID: 0030341308     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1996.37.6.371     Document Type: Article

References (29)

1. Baimain A, Ramsden M, Bowden GT, Smith J: Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658-660, 1984
2. Barbacid M: Oncogenes and human cancer: cause or consequence? Carcinogenesis 7: 1037-1042, 1986
3. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987
4. Barbacid M: Ras oncogenes: their role in neoplasm. Eur J Clin Invest 20: 225-235, 1990
5. Bishop JM: Cellular oncogenes and retroviruses. Annu Rev Biochem 52: 301-354, 1983
6. Bonfanti M, Magagnotti C, Bonati M, Fanelli R, Airoldi L: Pharmacokinetic profile and metabolism of N-nitrosobutyl (4-hydroxybutyl) amine in rats. Cancer Res 48: 3666-3669, 1988
7. Bos JL: Ras oncogenes in human cancer: A Review. Cancer Res 49: 4682-4689, 1989
8. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987
9. Burchill SA, Eunec J, Mellon K, Neal DE: Analysis of Ha-ras mutations in primary bladder tumors. Br J Cancer 63 (Suppl 3): 62, 1991
10. Czerniak B, Deitch D, Simmons H, Etkind P, Herz F, Koss LG: Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br J Cancer 62: 762-763, 1990
11. Der DJ, Finkel T, Cooper GM: Biological and biochemical properties of human ras genes mutated at codon 61. Cell 44: 167-176, 1986
12. Enomoto T, Ward JM, Perantoni AO: H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydro-xybutyl)nitrosamine. Carcinogenesis 11: 2233-2238, 1990
13. Fujita J, Kraus MH, Onoue H, Srivastava SK, Ebi Y, Kitamura Y, Rhim JS: Activated H-ras oncogenes in human kidney tumors. Cancer Res 48: 5251-5255, 1988
14. Fujita J, Srivastesva SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA: Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 82: 3849-3853, 1985
15. Grimmond SM, Raghavan D, Russell PJ: Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urol Res 20: 121-126, 1992
16. Heim S, Mitelman F: Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements. Hum Genet 75: 70-72, 1987
17. Knowles MA, Williamson M: Mutation of H-ras is infrequent in bladder cancer: Confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms and direct sequencing. Cancer Res 53: 133-139, 1993
18. Kraus MH, Yuasa Y, Aaronson SA: A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci USA 81: 5384-5388, 1984
19. Land H, Parada LF, Weinberg RA: Cellular oncogenes and multistep carcinogenesis. Science 222: 771-778, 1983
20. Nobuo M, Takashi U, Hideyuki A, Jun T, Tadaichi K, Toshikazu M, Kazuki K, Yoshio A: Expression of ras p21 Oncogene Product on Human Bladder Tumors. Urol Int 44: 260-263, 1989
21. Shiro S: Detection of H-ras Gene Point Mutations in Transitional Cell Carcinoma of Human Urinary Bladder Using Polymerase Chain Reaction. Keio J Med 41: 80-86, 1992
22. Sigal IS, Gibbs JB, D'Alonzo JS, Temeles GL, Wolanski BS, Socher SH, Scolnick EM: Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects. Proc Natl Acad Sci USA 83: 952-956, 1986
23. Slamon DJ, Kernion JB, de Verma IM, Cline MJ: Expression of cellular oncogenes in human malignancies. Science 224: 256-262, 1984
24. Taparowsky E, Shimizu K, Goldfarb M, Wigler M: Structure and activation of the human N-ras gene. Cell 34: 581-586, 1983
25. VisVanathan KV, Pocock RD, Summerhayes IC: Preferential and novel activation of H-ras in human bladder carcinomas. Oncogene Res 3: 77-86, 1988
26. Walter M, Clark SG, Levinson AD: The oncogenic activation of human p21 ras by a novel mechanism. Science 233: 649-652, 1986
27. Yasuhiki N, Masumi A, Kohmei K, Shigeru S, Toshihiko K, Kazuhiro Y, Ryuzo U, Eiichi N, Hiroshi S: Point Mutations of c-ras Genes in Human Bladder Cancer and Kidney Cancer. Jpn J Cancer Res 81: 22-27, 1990
28. Yuasa Y, Gol RA, Chang A, Chiu IM, Reddy EP, Tronick SR, Aaronson SA: Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. Proc Natl Acad Sci USA 81: 3670-3674, 1984
29. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M: Direct mutagenesis of Ha-ras-I oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382-385, 1985